1) levocarnitine and sodium chloried injection
左旋卡尼汀氯化钠注射液
2) Levocarnitine Injection
左旋卡尼汀注射液
3) levocarnitine
左旋卡尼汀
1.
Study on the preparative process of levocarnitine and sodium chloride injection;
左旋卡尼汀氯化钠注射液制备工艺研究
2.
Determination of Levocarnitine Injection by HPLC;
HPLC法测定左旋卡尼汀注射液的含量
3.
HPLC measurement of levocarnitine content and related substances in levocarnitineand sodium chloride injection;
HPLC法测定左旋卡尼汀氯化钠注射液含量及有关物质
4) L-carnitine
左旋卡尼汀
1.
Effects of L-carnitine on Cardiac Insufficiency in Peritoneal Dialysis Patients with Uremia;
左旋卡尼汀对尿毒症腹透患者心功能不全的治疗作用
2.
Effects of L-carnitine on Ischemic-reperfusion Injury in Rabbit Cardiomyocytes in vivo;
左旋卡尼汀对心肌缺血/再灌注损伤的抗氧化作用
3.
Clinical Observation on L-carnitine in the Treatment of Unstable Angina Pectoris;
左旋卡尼汀治疗不稳定型心绞痛疗效观察
5) L carnitine
左旋卡尼汀
1.
Objective To investigate the anti lipid peoxidation and improving the heart function effects of L carnitine (L CN)in patients with congestive heart failure (CHF).
目的 探讨左旋卡尼汀 (L CN)治疗充血性心力衰竭 (CHF)的临床疗效及抗氧化作用。
2.
L carnitine(the active isomer of carnitine) is essential to transfer long chain fatty acid acrosses the mitochondrial membrane to undergo beta oxidation.
通过静脉注射、口服、透析液补充外源性左旋卡尼汀有利于纠正脂代谢紊乱 ,减少促红细胞生成素用量 ,改善骨骼肌症状和营养状态 ,提高生活质量。
3.
This paper is to investigate the effects of L carnitine( L CN) on levels of superoxide dismutase(SOD) and malondialdehyde(MDA) in patients with congestive heart failure(CHF).
选择充血性心衰 (CHF)患者 5 0例随机分为两组 ,对照组 (2 5例 )予常规药物治疗 ,左旋卡尼汀 (L- CN)组 (2 5例 )予常规药物 +L- CN治疗。
6) carbazochrime sodium sulfonate injection
卡络磺钠氯化钠注射液
1.
OBJECTIVE To establish the quality standard for the bacterial endotoxins test of carbazochrime sodium sulfonate injection.
目的建立卡络磺钠氯化钠注射液的细菌内毒素检查的方法。
补充资料：左卡尼汀富马酸盐
分子式：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：暂无
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条